Abiopharma

Immutep Limited (IMMP) Files Form 6-K

Annual Reports and Related Documents:

Annual Reports and Related Documents:

Financial Statements and Related Announcement: Full Yearly Results

Annual General Meeting :

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

General Announcement: DEALINGS DURING CLOSED PERIOD

Medi Lifestyle - Announcement

Meihua International Medical Technologies Co Ltd (MHUA) was removed from the list of traded instruments on NASDAQ exchange

Labeling changes approved for RISING. Active ingredient: EPLERENONE. Decision date: 12/04/2025

General Announcement: PROPOSED DEBT CONVERSION INTO NEW ORDINARY SHARES - RECEIPT OF LISTING AND QUOTATION NOTICE

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

NASDAQ symbol attribute type Security_Name was changed. Previous value: Meihua International Medical Technologies Co., Ltd. - Class A Ordinary Shares. New value: Meihua International Medical Technologies Co., Ltd. - Class A Ordinary Shares.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Meihua International Medical Technologies Co., Ltd. - Class A Ordinary Shares.